Histogen Obtains $10,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    9855 Towne Centre Drive San Diego, CA 92121
  • Company Description
    Histogen, launched in 2007, seeks to redefine regenerative medicine by developing a series of high value products without the use of embryonic stem cells or animal products. Through Histogen’s proprietary bioreactors that mimic the embryonic environment, newborn fibroblasts are encouraged to naturally produce the vital proteins and growth factors from which the company has developed its rich product portfolio.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Histogen has recently moved into a new facility that will allow for up-scaled manufacturing for its upcoming clinical trials, and later commercial production.
  • M&A Terms
  • Venture Investor
    Secure Medical, Inc.
  • Venture Investor

Trending on Xconomy